共 50 条
- [4] TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (01): : 38 - 45
- [7] A phase II trial design based on median time-to-event CONTROLLED CLINICAL TRIALS, 2003, 24 : 225S - 225S